These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 26994841)
1. Synthesis, cytotoxic activity evaluation and HQSAR study of novel isosteviol derivatives as potential anticancer agents. Liu CJ; Yu SL; Liu YP; Dai XJ; Wu Y; Li RJ; Tao JC Eur J Med Chem; 2016 Jun; 115():26-40. PubMed ID: 26994841 [TBL] [Abstract][Full Text] [Related]
2. Syntheses, cytotoxic activity evaluation and HQSAR study of 1,2,3-triazole-linked isosteviol derivatives as potential anticancer agents. Liu CJ; Liu YP; Yu SL; Dai XJ; Zhang T; Tao JC Bioorg Med Chem Lett; 2016 Nov; 26(22):5455-5461. PubMed ID: 27777008 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, cytotoxic activity, and 2D- and 3D-QSAR studies of 19-carboxyl-modified novel isosteviol derivatives as potential anticancer agents. Liu CJ; Zhang T; Yu SL; Dai XJ; Wu Y; Tao JC Chem Biol Drug Des; 2017 Jun; 89(6):870-887. PubMed ID: 27878967 [TBL] [Abstract][Full Text] [Related]
4. D-ring modified novel isosteviol derivatives: design, synthesis and cytotoxic activity evaluation. Zhang T; Lu LH; Liu H; Wang JW; Wang RX; Zhang YX; Tao JC Bioorg Med Chem Lett; 2012 Sep; 22(18):5827-32. PubMed ID: 22901386 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and cytotoxic activity of MOM-ether analogs of isosteviol. Malki A; Laha R; Bergmeier SC Bioorg Med Chem Lett; 2014 Feb; 24(4):1184-7. PubMed ID: 24444475 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticancer evaluation of complex unsaturated isosteviol-derived triazole conjugates. Khaybullin RN; Liang X; Cisneros K; Qi X Future Med Chem; 2015; 7(18):2419-28. PubMed ID: 26653151 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and cytotoxic evaluation of nitric oxide-releasing derivatives of isosteviol. Liu Y; Wang T; Ling Y; Bao N; Shi W; Chen L; Sun J Chem Biol Drug Des; 2017 Sep; 90(3):473-477. PubMed ID: 28122177 [TBL] [Abstract][Full Text] [Related]
8. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents. Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization and Qi XX; Wang PP; Cui LT; Jin M; Zhao LX; Li G J Asian Nat Prod Res; 2024 Jul; 26(7):812-823. PubMed ID: 38477295 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of glaucocalyxin A derivatives as potential anticancer agents. Yang J; Liu Y; Xue C; Yu W; Zhang J; Qiao C Eur J Med Chem; 2014 Oct; 86():235-41. PubMed ID: 25164762 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxic activity of nitric oxide-releasing isosteviol derivatives. Wang TT; Liu Y; Chen L Bioorg Med Chem Lett; 2014 May; 24(9):2202-5. PubMed ID: 24685545 [TBL] [Abstract][Full Text] [Related]
12. Design and Synthesis of C-19 Isosteviol Derivatives as Potent and Highly Selective Antiproliferative Agents. Luan T; Cao LH; Deng H; Shen QK; Tian YS; Quan ZS Molecules; 2018 Dec; 24(1):. PubMed ID: 30598028 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of isosteviol triazole conjugates for cancer therapy. Khaybullin RN; Zhang M; Fu J; Liang X; Li T; Katritzky AR; Okunieff P; Qi X Molecules; 2014 Nov; 19(11):18676-89. PubMed ID: 25405286 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro cytotoxic activity evaluation of novel heterocycle bridged carbothioamide type isosteviol derivatives as antitumor agents. Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM Bioorg Med Chem Lett; 2013 Mar; 23(5):1343-6. PubMed ID: 23347685 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, cytotoxicity and antiplasmodial activity of novel ent-kaurane derivatives. Batista R; García PA; Castro MA; Miguel Del Corral JM; Speziali NL; de P Varotti F; de Paula RC; García-Fernández LF; Francesch A; San Feliciano A; de Oliveira AB Eur J Med Chem; 2013 Apr; 62():168-76. PubMed ID: 23353738 [TBL] [Abstract][Full Text] [Related]
16. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies. Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140 [TBL] [Abstract][Full Text] [Related]
17. Stereoselective synthesis of 15- and 16-substituted isosteviol derivatives and their cytotoxic activities. Wu Y; Dai GF; Yang JH; Zhang YX; Zhu Y; Tao JC Bioorg Med Chem Lett; 2009 Mar; 19(6):1818-21. PubMed ID: 19223180 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel oridonin analogues as potent anticancer agents. Shen QK; Chen ZA; Zhang HJ; Li JL; Liu CF; Gong GH; Quan ZS J Enzyme Inhib Med Chem; 2018 Dec; 33(1):324-333. PubMed ID: 29303372 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and Cytotoxicity Assessment of Novel 7-O- and 14-O-Derivatives of Glaucocalyxin A. Liu HC; Qiao LM; Zheng W; Xiang ZB; Chen HS; Yu SC; Zhang DZ; Wang T; Zhang YF; Jin YS Anticancer Agents Med Chem; 2020; 20(10):1241-1249. PubMed ID: 32116205 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway. Shen QK; Deng H; Wang SB; Tian YS; Quan ZS Eur J Med Chem; 2019 Jul; 173():15-31. PubMed ID: 30981113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]